Regulation of eicosanoid-like compound biosynthesis by IFN-gamma, IL-6, and EPA in human breast cancer cell line.
Yang
C Y
CY
Department of Dent., Tri-Serv. Gen. Hosp., Taipei, Taiwan, R.O.C.
Meng
C L
CL
Shen
K L
KL
Wong
P Y
PY
Lee
H K
HK
D000230:Adenocarcinoma / Q000378:metabolism / Q000473:pathology*; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D002851:Chromatography, High Pressure Liquid; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D015777:Eicosanoids / Q000096:biosynthesis*; D015118:Eicosapentaenoic Acid / Q000494:pharmacology*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007371:Interferon-gamma / Q000494:pharmacology*; D015850:Interleukin-6 / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000187:drug effects; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D015777:Eicosanoids; D015850:Interleukin-6; D003907:Dexamethasone; D007371:Interferon-gamma; D015118:Eicosapentaenoic Acid; D007213:Indomethacin